Published in

Elsevier, Vaccine, 24(33), p. 2830-2841, 2015

DOI: 10.1016/j.vaccine.2015.02.052

Disease Control Priorities, Third Edition (Volume 3): Cancer, p. 295-305

DOI: 10.1596/978-1-4648-0349-9_ch18

Links

Tools

Export citation

Search in Google Scholar

An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO